A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

Christina L. Roland(The University of Texas MD Anderson Cancer Center), Neeta Somaiah(The University of Texas MD Anderson Cancer Center)
Nature Cancer
February 13, 2024
10.1038/s43018-024-00726-z
Cited by 53

Related Papers

Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
|Annals of Surgical Oncology|2021|243